DLTR
52
8
NOV
45
2
PFG
27
7
GIS
47
13
JPM
59
6
FOXA
67
5
EMC
30
-26
COF
48
3
ADT
12
2
SPG
45
2
PEP
33
4
LUV
45
3
MCO
67
3
EQIX
59
2
CMA
42
3
AIG
38
5
CNP
59
17
CAT
47
3
DVA
62
5
PVH
58
5
DLTR
52
8
NOV
45
2
PFG
27
7
GIS
47
13
JPM
59
6
FOXA
67
5
EMC
30
-26
COF
48
3
ADT
12
2
SPG
45
2
PEP
33
4
LUV
45
3
MCO
67
3
EQIX
59
2
CMA
42
3
AIG
38
5
CNP
59
17
CAT
47
3
DVA
62
5
PVH
58
5
Financhill
Back

Virtus LifeSci Biotech Clinical Trials ETF Stock Predictions

These 7 Stocks Will Be Magnificent in 2025

Get Your Copy of "These 7 Stocks Will Be Magnificent in 2025" Here.
Sell
40

BBC
Virtus LifeSci Biotech Clinical Trials ETF

Last Price:
$24.33
Seasonality Move:
-1.26%

7 Day Trial

ALL ACCESS PASS

$ 7

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Virtus LifeSci Biotech Clinical Trials ETF Stock Forecast

  • Over the next 52 weeks, Virtus LifeSci Biotech Clinical Trials ETF has on average historically risen by 3.5% based on the past 9 years of stock performance.
  • Virtus LifeSci Biotech Clinical Trials ETF has risen higher in 4 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 44.44%
  • Is Virtus LifeSci Biotech Clinical Trials ETF Stock Undervalued?
    The current Virtus LifeSci Biotech Clinical Trials ETF [BBC] share price is $24.33. The Score for BBC is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • BBC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Virtus LifeSci Biotech Clinical Trials ETF Stock Go Up Next Year?

  • Over the next 52 weeks, Virtus LifeSci Biotech Clinical Trials ETF has on average historically risen by 3.5% based on the past 9 years of stock performance.

Virtus LifeSci Biotech Clinical Trials ETF Stock Rating

Sell
40
Virtus LifeSci Biotech Clinical Trials ETF (BBC) is a Sell

Is Virtus LifeSci Biotech Clinical Trials ETF overpriced?

  • Virtus LifeSci Biotech Clinical Trials ETF has risen higher in 4 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 44.44%

Virtus LifeSci Biotech Clinical Trials ETF Stock Price History

Is BBC stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BBC is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NYSEARCA
Country:
Industry:
Sector:
Type:
etf
Website:

52-Week Data

52-Week High:
31.99
52-Week Low:
23.60

Prediction Charts

Market Cap:
0
Price in USD:
24.33
Volume:
1.2K
Beta:
1.28

Technical Analysis

SMA50:
27.99
SMA100:
27.75
SMA200:
27.52
52-Wk Change:
9.39%

Stock Predictions

  • Is Virtus LifeSci Biotech Clinical Trials ETF stock public?
    Yes, Virtus LifeSci Biotech Clinical Trials ETF is a publicly traded company.
  • What is the Virtus LifeSci Biotech Clinical Trials ETF stock quote today?
    The Virtus LifeSci Biotech Clinical Trials ETF stock price is 24.33 USD today.
  • How to buy Virtus LifeSci Biotech Clinical Trials ETF stock online?
    You can buy Virtus LifeSci Biotech Clinical Trials ETF shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-3 27.50 26.83 27.50 26.70
Dec-4 26.84 26.93 27.10 26.77
Dec-5 26.59 26.29 26.65 26.28
Dec-6 26.64 27.32 27.36 26.64
Dec-9 27.28 27.08 27.33 27.08
Dec-10 27.44 27.17 27.49 27.10
Dec-11 27.21 26.97 27.21 26.69
Dec-12 26.50 25.56 26.58 25.56
Dec-13 25.12 25.05 25.12 25.02
Dec-16 25.18 25.55 25.68 25.18
Dec-17 25.39 25.49 25.56 25.37
Dec-18 24.94 23.90 25.22 23.84
Dec-19 24.03 24.23 24.38 23.96
Dec-20 24.13 24.33 24.52 24.13

Virtus LifeSci Biotech Clinical Trials ETF Earnings

Data Unavailable

Virtus LifeSci Biotech Clinical Trials ETF Forecast Revenue Growth

Data Unavailable

* Virtus LifeSci Biotech Clinical Trials ETF stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.